Study: PEATY
24/09/2024
Patients' experiences of abemaciclib plus endocrine therapy (ET) in adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer (EBC): a preliminary qualitative interview study
Study: IMPACTOR
24/09/2024
Early supportive interventions needed to reduce treatment burden of abemaciclib + endocrine therapy in metastatic breast cancer
Study: TRUSTING Workshops 2022-23 Evaluation
30/06/2024
Roll out and influence of an educational program Talking about Risk, UncertaintieS of Testing IN Genetics (TRUSTING)
Study: TRUSTING Workshops 2022-23 Evaluation
22/01/2024
Roll out and influence on practice of the Talking about Risk, Uncertainties of Testing in Genetics (TRUSTING) educational programme
Study: PRRS - Patient Roles and Responsibilities Scale
22/01/2024
The Patient Roles and Responsibilities Scale (PRRS): a psychometrically robust and useful tool to measure what matters most to patients
Study: LORIS
22/01/2024
The challenges of recruiting women with low-risk ductal carcinoma in situ to a randomised controlled trial: the LORIS study experience
Study: IMPARTER 4
19/01/2024
IMPARTER:4 IMproving PAtient undeRstanding of Gene Expression Profiling Test Results: Phase 4
Study: LIMBER
19/01/2024
Exploring the support needs of women LIvingwith Metastatic Breast cancER: a qualitative analysis of the LIMBER survey
Study: LIMBER 2 - They just don't know what to say or do
09/11/2023
Development of an information film for friends & family of patients with MBC "They just don't know what to say or do"
Study: DIAMOND Phase 1-4
06/12/2022
'Gastrostomy Tube: Is it for Me?' Development and pilot testing of a web-based patient decision aid for people with motor neurone disease considering a gastrostomy tube (DiAMoND Study)
Study: DIAMOND Phase 1-4
28/11/2022
Development and pilot testing of a web-based decision aid for people with motor neurone disease considering a gastrostomy tube (DiAMoND Study)
Study: IMPARTER Phase 1
07/12/2021
An intervention to help improve understanding of gene expression profiling tests in breast cancer: Which is best, an information film or leaflet?
Study: PRAGMATIC
11/11/2021
Patients' experiences of a suppoRtedself-manAGeMentpAThwayIn breast Cancer (PRAGMATIC): 3 month Quality of Life Results
Study: PRAGMATIC
11/11/2021
Patients' experiences of a suppoRted self-manAGeMent pAThway In breast Cancer (PRAGMATIC)
Study: REFLECTIONS
11/11/2021
Oncologists and patients believe more training is needed in telehealth and carers and nurses need inclusion
Study: Nepal womens cancer scoping review (IRP)
01/11/2021
A scoping review to determine levels of knowledge, attitudes and screening practices towards breast and cervical cancer among women in Nepal
Study: Transgender project (IRP)
01/11/2021
A scoping review of cancer screening in the transgender population: uptake, barriers and healthcare professional knowledge
Study: TRUSTING Workshops 2020-21 Evaluation
01/04/2021
TRUSTING: The development of a communication program for healthcare professionals talking about risk and uncertainty of testing in genetics
Study: PRAGMATIC
27/02/2020
Patients' experiences of a suppoRted self-manAGeMent pAThway In breast Cancer (PRAGMATIC)
Study: Related
01/02/2020
Measuring diarrhoea in a cancer setting: the importance of patient-reported tools
Study: TARGET Workshops - Talking About Risk in the context of Genomic Tests (TARGET)
19/12/2019
Results from a novel education program to help nurses when discussing the Onoctype DX Breast Recurrence Score test with their patients
Study: POSNOC
06/10/2019
Measuring patient reported outcomes in the POSNOC trial: Strategies employed to promote high quality data return
Study: TARGET Workshops - Talking About Risk in the context of Genomic Tests (TARGET)
11/04/2019
Talking About Risk in the Context of GEnomicTests (TARGET) Evaluation of an educational programme
Study: AVALPROFS
04/11/2018
Hoping against hope: Are patients' expectations and understanding about therapeutic aims of novel drugs similar to their oncologists?
Study: Extreqol
19/10/2018
Patients' and partners' views of treatment and care provided for metastatic castrate resistant prostate cancer (mCRPC) in the UK
Study: PEPSIN
01/03/2018
PEPSIN Psychobiological Effects of Personalised Supportive INterventions: a feasibility study
Study: LORIS
05/12/2017
Interviews with women contemplating LORIS trial entry: 2 year feasibility study
Study: PROACT
01/11/2017
Evaluation of Construct and Structural Validity in the Patient Roles and Responsibilities Scale
Study: ENDOPREDICT
08/09/2017
Enhanced decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing
Study: CU FITTER
22/06/2017
How to keep active with cancer? Cancer survivors' experiences of a tailored exercise programme CUFITTERTM: results of an explorative survey
Study: Extreqol
16/06/2017
Survey Results on Managing Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Study: CU FITTER
16/03/2017
Exercise levels and experiences of those attending CUFITTER a tailored exercise programme for people incancer recovery
Study: PROACT
01/03/2017
Patient Reported Outcomes in cancer, impact of Age and Carer role demands associated with Treatment (PROACT): The 'lucky' construct
Study: AVALPROFS
27/01/2017
Assessing the VALue to patients of PROgression Free Survival (AVALPROFS) Quality of Life Results
Study: PROACT
01/01/2017
Evaluation and validation of the proact measures for cancer patients and informal caregivers
Study: PrefHer
01/10/2016
Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study
Study: PROACT
01/10/2016
Patient Reported Outcomes in Cancer, Impact of Age and Carer Role Demands Associated with Treatment (PROACT): Phase 1 Development of Scale Items
Study: bWell
09/03/2016
bWell: a mobile application for self-management of arm and shoulder exercises after breast cancer treatment
Study: PROACT
27/09/2015
Uncertainty about the future for patients with advanced cancer and their informal caregivers: A qualitative view
Study: PROACT
27/09/2015
Measuring the impact of extended cancer survival on broader aspects of life and well being: The PROACT study
Study: EXPECT
25/09/2015
Gaps and inconsistencies: Information for men with metastatic castrate resistant prostate cancer (mCRPC)
Study: PROACT
02/09/2015
Patient reported outcome measures for cancer caregivers: A systematic review
Study: Chemotherapy and Cognition
18/03/2015
Feasibility study to examine underlying mechanisms for "chemo-cog"
Study: PrefHer
01/09/2013
Reasons for patients' preferences for subcutaneous or intravenous trastuzumab in the PrefHer study
Study: PrefHer
01/03/2013
PATIENT PREFERENCE FOR SUBCUTANEOUS VERSUS INTRAVENOUS ADJUVANT TRASTUZUMAB: RESULTS OF THE PREFHER STUDY
Study: Teams Talking Trials
01/01/2010
Communication skills training for breast cancer teams talking about trials
Study: ALMANAC
03/12/2004
Impact of sentinel node biopsy on quality of life in the ALMANAC trial.
Study: Communicating about RCTs films
21/05/2004
Efficacy of an Intervention to Improve Communication About Randomised Clinical Trials (RCTs) in Cancer
LIMBER2 - They just don't know what to say or do
Professor Val Jenkins presenting at the ABC (Advanced Breast Cancer) Conference in Lisbon, November 2023
Knowledge of risk factors and symptoms associated with breast and ovarian cancer among people living in LMICs in Eastern Africa: A scoping review
Implementing the routine use of patient reported outcome measures in oncology clinical practice to improve patient and clinical outcomes
